IV immuno-oncolytic virus

Struggling Oncolytics Biotech signs $86.6M Asia deal with China’s Adlai Nortye
Endpoints
Fri, 11/17/17 - 10:21 am
Oncolytics
China
IV immuno-oncolytic virus
Adlai Nortye